ADVANCED ENZYME TECHNOLOGIES Financial Statement Analysis
|
||
The Revenues of ADVANCED ENZYME TECHNOLOGIES have increased by 2.13% YoY .
The Earnings Per Share (EPS) of ADVANCED ENZYME TECHNOLOGIES has decreased by -11.68 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
ADVANCED ENZYME TECHNOLOGIES Last 5 Annual Financial Results
[BOM: 540025|NSE : ADVENZYMES]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹541 Cr | ₹529 Cr | ₹502 Cr | ₹444 Cr | ₹420 Cr |
Expenses | ₹383 Cr | ₹327 Cr | ₹269 Cr | ₹241 Cr | ₹237 Cr |
Operating Profit (Excl OI) | ₹157 Cr | ₹203 Cr | ₹233 Cr | ₹203 Cr | ₹183 Cr |
Other Income | ₹25 Cr | ₹6.42 Cr | ₹8.85 Cr | ₹5.88 Cr | ₹5.72 Cr |
Interest | ₹3.48 Cr | ₹2.96 Cr | ₹2.57 Cr | ₹4.08 Cr | ₹5.20 Cr |
Depreciation | ₹35 Cr | ₹35 Cr | ₹29 Cr | ₹26 Cr | ₹21 Cr |
Profit Before Tax | ₹140 Cr | ₹171 Cr | ₹210 Cr | ₹179 Cr | ₹162 Cr |
Profit After Tax | ₹104 Cr | ₹124 Cr | ₹151 Cr | ₹133 Cr | ₹116 Cr |
Consolidated Net Profit | ₹106 Cr | ₹120 Cr | ₹146 Cr | ₹129 Cr | ₹111 Cr |
Earnings Per Share (Rs) | ₹9.45 | ₹10.70 | ₹13.06 | ₹11.58 | ₹9.95 |
PAT Margin (%) | 19.18 | 23.34 | 29.88 | 29.96 | 27.62 |
ROE(%) | 8.94 | 12.04 | 16.77 | 17.61 | 18.82 |
ROCE(%) | 12.26 | 16.66 | 22.93 | 23.21 | 24.96 |
Total Debt/Equity(x) | 0.01 | 0.01 | 0.02 | 0.03 | 0.05 |
Key Financials |
||
Market Cap | : | ₹ 4,019.2 Cr |
Revenue (TTM) | : | ₹ 604.8 Cr |
Net Profit(TTM) | : | ₹ 139.2 Cr |
EPS (TTM) | : | ₹ 12.5 |
P/E (TTM) | : | 28.9 |
Industry Peers & Returns | 1W | 1M | 1Y |
ADVANCED ENZYME TECHNOLOGIES | 1.5% | -13.2% | 47.9% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
ADVANCED ENZYME TECHNOLOGIES Revenues
[BOM: 540025|NSE : ADVENZYMES]
Y-o-Y | 2.13 % |
5 Yr CAGR | 6.54 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹541 Cr | 2.13 | |
Mar2022 | ₹529 Cr | 5.49 | |
Mar2021 | ₹502 Cr | 13.03 | |
Mar2020 | ₹444 Cr | 5.81 | |
Mar2019 | ₹420 Cr | - |
ADVANCED ENZYME TECHNOLOGIES Operating Profit
[BOM: 540025|NSE : ADVENZYMES]
Y-o-Y | -22.25 % |
5 Yr CAGR | -3.62 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹157 Cr | -22.25 | |
Mar2022 | ₹203 Cr | -12.90 | |
Mar2021 | ₹233 Cr | 14.49 | |
Mar2020 | ₹203 Cr | 11.27 | |
Mar2019 | ₹183 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -23.88 % |
5 Yr CAGR | -9.54 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 29.13% | -23.88 | |
Mar2022 | 38.27% | -17.41 | |
Mar2021 | 46.34% | 1.29 | |
Mar2020 | 45.75% | 5.15 | |
Mar2019 | 43.51% | - |
ADVANCED ENZYME TECHNOLOGIES Profit After Tax
[BOM: 540025|NSE : ADVENZYMES]
Y-o-Y | -11.66 % |
5 Yr CAGR | -1.24 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹106 Cr | -11.66 | |
Mar2022 | ₹120 Cr | -18.06 | |
Mar2021 | ₹146 Cr | 12.87 | |
Mar2020 | ₹129 Cr | 16.42 | |
Mar2019 | ₹111 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -17.82 % |
5 Yr CAGR | -8.71 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 19.18 % | -17.82 | |
Mar2022 | 23.34 % | -21.89 | |
Mar2021 | 29.88 % | -0.27 | |
Mar2020 | 29.96 % | 8.47 | |
Mar2019 | 27.62 % | - |
ADVANCED ENZYME TECHNOLOGIES Earnings Per Share (EPS)
[BOM: 540025|NSE : ADVENZYMES]
Y-o-Y | -11.68 % |
5 Yr CAGR | -1.28 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹9.45 | -11.68 | |
Mar2022 | ₹11 | -18.07 | |
Mar2021 | ₹13 | 12.78 | |
Mar2020 | ₹12 | 16.38 | |
Mar2019 | ₹9.95 | - |
ADVANCED ENZYME TECHNOLOGIES Return on Capital Employed (ROCE)
[BOM: 540025|NSE : ADVENZYMES]
Y-o-Y | -26.41 % |
5 Yr CAGR | -16.28 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 12.26% | -26.41 | |
Mar2022 | 16.66% | -27.34 | |
Mar2021 | 22.93% | -1.21 | |
Mar2020 | 23.21% | -7.01 | |
Mar2019 | 24.96% | - |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Current Share Price | : | ₹359.5 |
Current MarketCap | : | ₹ 4,019.2 Cr |
Updated EOD on | : | Apr 18,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | 1.5% |
-13.2% |
47.9% |
SENSEX | -2.9% |
-0.4% |
20% |
ADVANCED ENZYME TECHNOLOGIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | -1.1% | 11.8% | 62% |
S&P BSE MIDSMALLCAP | -1.2% | 9.4% | 62.3% |
S&P BSE ALLCAP | -2.2% | 3.9% | 37% |
S&P BSE HEALTHCARE | -3.1% | 2.5% | 51.1% |
You may also like the below Video Courses
FAQ about ADVANCED ENZYME TECHNOLOGIES Financials
How the annual revenues of ADVANCED ENZYME TECHNOLOGIES have changed ?
The Revenues of ADVANCED ENZYME TECHNOLOGIES have increased by 2.13% YoY .
How the Earnings per Share (EPS) of ADVANCED ENZYME TECHNOLOGIES have changed?
The Earnings Per Share (EPS) of ADVANCED ENZYME TECHNOLOGIES has decreased by -11.68 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs